Stock Ticker

  • Loading stock data...

Get Prepared for the Resurgence of the CBD Theme (CURLF, GWPH, HMPQ, CVSI)

Mainstream consumer adoption of CBD products represents a tailwind set to push overall CBD sector growth in the quarters ahead. This year alone is expected to show growth of over 900% in the space as mainstream big-brand retailers – such as Kroger’s, Walgreens, Walmart, Rite-Aid, and others – begin to carry CBD products in plain […]

HMPQ Selected for Exclusive Partnership with New Ally CBDSmartDecision.com

The CBD juggernaut is unmistakable. The substance has become synonymous with “sudden health and wellness revelation” in the US domestic market over the past year. But investors have a harder time with the issue because they actually have to attempt to understand whether or not it will live up to the insane hype that has […]

Dollar Tree (NASDAQ:DLRT) Receives Warning From FDA Regarding Adulterated Drugs

Dollar Tree (NASDAQ:DLRT) has received a warning from the Food and Drug Administration about the importation of adulterated drugs from foreign manufacturers. The potentially over the counter drugs include Assured brand drugs and acne treatment pads. Dollar Tree offering adulterated products On November 6, the FDA sent a warning letter to the discount retailer regarding […]

Looking Around the Corner in the CBD Boom (CVSI, CWBHF, GDET, ACB)

The refresh is on the way in the CBD market. That should be at the top of the list for aggressive growth investors and professional investment managers looking out the next 12 months because the CBD space is the most obvious ground-zero theme for “shocking growth” anywhere to be found in capital markets. “Cloud” is […]

AVEO Pharmaceuticals, Inc.’s (NASDAQ:AVEO) TIVO-3 Trial Results Inconclusive And Uninterpretable

AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) issued a regulatory update after a meeting with the U.S. FDA to discuss data from the August 2019 OS analysis of the TIVO-3 study. The company also issued an update on its proposal to advance with a New Drug Application for tivozanib. The TIVO-3 study was planned to resolve the FDA’s […]

Itau Unibanco Holding SA (NYSE:ITUB) Gets A Breather To Proceed With Credit Card Payments To Its Customers

In a chat with journalists, Candido Bracher, Chief Executive Officer of Itau Unibanco Holding SA (NYSE:ITUB), said the bank received an order to proceed with credit card payments to its customers. Cade opens an investigation Itau processes the payments of clients, who own an account in Itau, through Rede much faster. It has caught the […]

Occidental (NYSE:OXY) Cuts Spending To Manage Its Losses

Occidental Petroleum Corp (NYSE:OXY) announced that it would be putting on its big projects by 40% next year. This comes after its acquisition of Anadarko Petroleum for $38 billion. This deal contributed to Occidental not meeting its revenue targets, hence, the decision to cut on the spending the coming year. Moreover, the Anadarko deal led […]

Three Ways to Play the Healthcare Services Growth Boom (MDRX, RXMD, CERN)

Healthcare is always in the spotlight these days. Companies that manage to find a way to add value while increasing the efficiency equation can do society a great deal of good. But the growth numbers we see in the space right now mean that this space is also set to do a lot of good […]

ISWH Share Price Defies Logic as Company Announces Booming Quarter and Big Partnership

The story for International Spirits & Wellness Holdings, Inc. (OTCMKTS:ISWH) continues to explode onto the radar for speculators interested in massively undervalued stocks. The company just put out a new press release this morning demonstrating the full and remarkable scale of the turnaround story in play here. Record quarterly results. Huge revenue growth. Major partnership […]

This info on Agile Therapeutics, Inc. (AGRX) could trigger a massive change in trading

Agile Therapeutics, Inc. (AGRX) has received an average target price from analysts of 4.40 amounting to a recommendation rating of Buy. That comes from 6 different analysts. Perhaps, the driver for that assessment comes from the company’s valuations. To give a sense of trend, the same data point on the estimate for next year is […]

Sign Up To Get Our Latest Stocks Alerts